| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 74,655 | 52,228 | 33,521 | | Cost of Revenue | 20,307 | 13,534 | 7,621 | | | Gross Profit | 54,348 | 38,694 | 25,900 | | | Operating Expenses | | Research Development | 12,899 | 9,032 | 5,062 | | Selling General and Administrative | 39,166 | 25,332 | 18,406 | | Non Recurring | 23,501 |
-
|
-
| | Others | 1,407 | 1,116 | 1,383 | | | | Total Operating Expenses | 76,973 |
-
|
-
| | | | Operating Income or Loss | (22,625) | 3,214 | 1,049 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 329 | 896 | 715 | | Earnings Before Interest And Taxes | (22,296) | 4,110 | 1,764 | | Interest Expense | 376 |
-
|
-
| | Income Before Tax | (22,672) | 4,110 | 1,764 | | Income Tax Expense | 1,165 | (1,711) | (438) | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (23,837) | 5,821 | 2,202 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (23,837) | 5,821 | 2,202 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($23,837) | $5,821 | $2,202 |
|
1.48% Nasdaq 
Income Statement
